Loading...
Docoh

International Isotopes (INIS)

International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. It operates through the following segments: Radiochemical Products, Cobalt Products, Nuclear Medicine Products, Radiological Services and Fluorine Products. The Radiochemical Products segment includes production and distribution of various isotopically pure radio chemicals for medical, industrial, or research applications. The Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for tele therapy or irradiation devices, and recycling of expended cobalt sources. The Nuclear Medicine Products segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Radiological Services Segment concerns a wide array of miscellaneous services that consists of gemstone processing and field services that include source installation, removal, and radiation device decommissioning. The Fluorine Product segment involved the production of small scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. International Isotopes was founded in November 1995 and is headquartered in Idaho Falls, ID.

INIS stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

16 May 22
2 Jul 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 3.97M 3.97M 3.97M 3.97M 3.97M 3.97M
Cash burn (monthly) (no burn) (no burn) 125.35K 50.53K 285.96K 60.54K
Cash used (since last report) n/a n/a 384.21K 154.87K 876.5K 185.57K
Cash remaining n/a n/a 3.58M 3.81M 3.09M 3.78M
Runway (months of cash) n/a n/a 28.6 75.5 10.8 62.5

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
21 Feb 22 Steve Laflin Stock Option Common Stock Grant Acquire A No No 0.09 2,000,000 180K 2,000,000
21 Feb 22 Robert Atcher Stock Option Common Stock Grant Acquire A No No 0.09 2,000,000 180K 2,000,000
21 Feb 22 W Matthew Cox Stock Option Common Stock Grant Acquire A No No 0.09 1,000,000 90K 1,000,000
21 Feb 22 Christopher G Grosso Stock Option Common Stock Grant Acquire A No No 0.09 2,000,000 180K 2,000,000
20 Jan 21 W Matthew Cox Common Stock Payment of exercise Dispose F No No 0.28 13,393 3.75K 49,107
20 Jan 21 W Matthew Cox Common Stock Option exercise Acquire M No No 0.06 62,500 3.75K 62,500
20 Jan 21 W Matthew Cox Stock Option Common Stock Option exercise Dispose M No No 0.06 62,500 3.75K 187,500
45.4% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 1 2 -50.0%
Opened positions 0 1 EXIT
Closed positions 1 0 NEW
Increased positions 0 0
Reduced positions 1 0 NEW
13F shares Current Prev Q Change
Total value 21.59M 11.75M +83.8%
Total shares 229.63M 230.28M -0.3%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Kennerman Associates 229.63M $21.59M -0.3%
Largest transactions Shares Bought/sold Change
Kennerman Associates 229.63M -631.03K -0.3%
Capital Square 0 -20K EXIT

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: advertising, announced, Committee, competitor, discontinued, disposal, drastically, European, fulfilled, half, installation, longer, merged, minimal, Pharmalogic, point, respectfully, sell, separately, short, sublease, unable, unexercised, waste
Removed: ability, accommodate, achieve, adequate, administered, Administration, Administrative, Aid, Anderson, applicable, ASC, assumed, borrow, breached, carrying, cesium, charge, claim, cleanup, Consulting, contamination, continuing, converted, corporate, corrective, delivered, delivery, Economic, eliminating, event, filing, final, General, growth, heightened, indemnification, indemnified, investment, involved, involving, KeyBank, lender, light, loan, location, matter, month, notification, onsite, outbreak, ownership, PAA, Paycheck, paying, pipeline, PPP, prepaid, procure, profitability, Program, projection, Protection, Reconciliation, recovery, reduce, refund, reimburse, relation, Relief, renegotiated, repay, request, requested, SBA, scheduled, secure, settlement, shown, Small, stopped, team, uncertainty, Washington, wrapping